About 7-(5-fluoropyrimidin-2-yl)-3-(1,2,4-triazol-4-yl)-1-oxa-7-azaspiro[4.4]nonane
7-(5-fluoropyrimidin-2-yl)-3-(1,2,4-triazol-4-yl)-1-oxa-7-azaspiro[4.4]nonane (PubChem CID 134071141) has the molecular formula C13H15FN6O
and a molecular weight of 290.30 g/mol. Its IUPAC name is 7-(5-fluoropyrimidin-2-yl)-3-(1,2,4-triazol-4-yl)-1-oxa-7-azaspiro[4.4]nonane.
Analyze 7-(5-fluoropyrimidin-2-yl)-3-(1,2,4-triazol-4-yl)-1-oxa-7-azaspiro[4.4]nonane with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 7-(5-fluoropyrimidin-2-yl)-3-(1,2,4-triazol-4-yl)-1-oxa-7-azaspiro[4.4]nonane?
The IUPAC name of 7-(5-fluoropyrimidin-2-yl)-3-(1,2,4-triazol-4-yl)-1-oxa-7-azaspiro[4.4]nonane (CID 134071141) is 7-(5-fluoropyrimidin-2-yl)-3-(1,2,4-triazol-4-yl)-1-oxa-7-azaspiro[4.4]nonane.
What is the SMILES notation for 7-(5-fluoropyrimidin-2-yl)-3-(1,2,4-triazol-4-yl)-1-oxa-7-azaspiro[4.4]nonane?
The canonical SMILES for 7-(5-fluoropyrimidin-2-yl)-3-(1,2,4-triazol-4-yl)-1-oxa-7-azaspiro[4.4]nonane is Fc1cnc(N2CCC3(CC(n4cnnc4)CO3)C2)nc1.
What is the InChIKey of 7-(5-fluoropyrimidin-2-yl)-3-(1,2,4-triazol-4-yl)-1-oxa-7-azaspiro[4.4]nonane?
The InChIKey is AMIRYMFIFHCMGP-UHFFFAOYSA-N. The full InChI is InChI=1S/C13H15FN6O/c14-10-4-15-12(16-5-10)19-2-1-13(7-19)3-11(6-21-13)20-8-17-18-9-20/h4-5,8-9,11H,1-3,6-7H2.
What are the key properties of 7-(5-fluoropyrimidin-2-yl)-3-(1,2,4-triazol-4-yl)-1-oxa-7-azaspiro[4.4]nonane?
7-(5-fluoropyrimidin-2-yl)-3-(1,2,4-triazol-4-yl)-1-oxa-7-azaspiro[4.4]nonane has a molecular weight of 290.30 g/mol, XLogP of 0.82, 2 rotatable bonds, 0 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 7-(5-fluoropyrimidin-2-yl)-3-(1,2,4-triazol-4-yl)-1-oxa-7-azaspiro[4.4]nonane is sourced from PubChem (CID 134071141), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).